TGFB1 and cardiac hypertrophy: Overexpression of TGF-β in transgenic mice leads to cardiac hypertrophy and fibrosis, whereas blockade of TGF-β with neutralizing antibodies inhibits hypertrophic and fibrotic responses [38, 39].